Innovative Approach for a Typology of Treatment Sequences in Early Stage HER2 Positive Breast Cancer Patients Treated With Trastuzumab in the French National Hospital Database

por Tredan, Olivier, Laurent, Marie, Gilberg, Melina, Ghorbal, Rim, Vainchtock, Alexandre, Lortet-Tieulent, Joannie, Prodel, Martin, Dupin, Julien
Publicado 2022

Long-term outcomes in patients with PET-predicted poor-responsive HER2-positive breast cancer treated with neoadjuvant bevacizumab added to trastuzumab and docetaxel: 5-year follow...

por Coudert, Bruno, Pierga, Jean-Yves, Mouret-Reynier, Marie-Ange, Kerrou, Kaldoun, Ferrero, Jean-Marc, Petit, Thierry, Du, Fanny Le, Dupré, Pierre-François, Bachelot, Thomas, Gabelle, Philippe, Chauvet, Marie-Pierre, Coeffic, David, Barbe, Catherine, Prevost, Jean-Briac, Paintaud, Gilles, Thibault, Gilles, Ferhat, Abdennour, Dupin, Julien, Berriolo-Riedinger, Alina, Arnould, Laurent
Publicado 2020